comparemela.com

Latest Breaking News On - Douglas loe - Page 2 : comparemela.com

Cardiol Therapeutics Inc is commercializing its THC-free cannabidiol formulation to treat heart disease

Cardiol Therapeutics Inc is commercializing its THC-free cannabidiol formulation to treat heart disease
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
America
Canadian
Douglas-loe
Leede-jones-gable
Andrew-hamer
David-elsley
Cardiometabolic-at-amgen-inc
Company-investigational-new-drug
Data-safety-monitoring-committee
Global-development

Cardiol Therapeutics Inc is commercializing its THC-free cannabidiol formulation to treat heart disease

Proprietary formulation produces ultra-pure pharmaceutical cannabidiol (CBD) without the psychotropic effects of THC for the treatment of inflammatory heart disease Received US FDA approval to commence a Phase II/III COVID-19 trial investigating the cardioprotective properties of CardiolRx Has launched Cortalex through a national agreement with Medical Cannabis by Shoppers to retail it on an exclusive basis across Canada Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease. The Canadian specialty pharmaceutical company has developed a proprietary formula of ultra-pure pharmaceutical cannabidiol (CBD) that does not contain THC - less than 5 parts per million (ppm) - and consequently none of the psychotropic effects of THC.

Canada
Toronto
Ontario
United-states
America
Canadian
Douglas-loe
Leede-jones-gable
Andrew-hamer
David-elsley
Cardiometabolic-at-amgen-inc
Data-safety-monitoring-committee

Dieses Unternehmen löst BioNTech & Pfizer's Impfstoffproblem mit Herzmuskelentzündungen!

Dieses Unternehmen löst BioNTech & Pfizer's Impfstoffproblem mit Herzmuskelentzündungen!
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United-states
Germany
Canada
Israel
Berlin
Israeli
Canadian
Douglas-loe
Bnp-stressmarker
Leede-jones-gable
Contor-gmbh
Matthias-friedrich

CareRx To Acquire The LTC Pharmacy Division Of Medical Pharmacies; Shares Pop 9%

CareRx To Acquire The LTC Pharmacy Division Of Medical Pharmacies; Shares Pop 9% Stephanie Bedard-Chateauneuf- April 19, 2021, 1:14 PM EDT SHARE ON: CareRx shares jumped more than 9% in early trading on Monday after the company announced that it has signed an agreement to acquire the Long-Term Care Pharmacy Division of Medical Pharmacies Group Limited. This acquisition adds approximatively 36,000 residents served and C$150 million in annual revenue. It is expected to pay off immediately with significant synergies. At closing, CareRx ( CRRX) expects to serve more than 88,000 residents, strengthening the company’s position as the leading provider of senior pharmacies in Canada CareRx President and CEO David Murphy said, “The acquisition of MPGL’s LTC Pharmacy Division is our most transformational acquisition to date and will increase the number of homes and residents we service by approximately 70%. MPGL�

Canada
Douglas-loe
David-murphy
Pharmacy-division
Long-term-care-pharmacy-division
Medical-pharmacies-group
Echelon-capital-markets
Wall-street
கனடா
டக்ளஸ்-லோ
டேவிட்-மர்பி
மருந்தகம்-பிரிவு

vimarsana © 2020. All Rights Reserved.